Is Viking Therapeutics Stock Going to $100? Key Signals
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Explore what makes the best high yield dividend ETF for retirees, focusing on yield stability, fees, and diversification. This quick intro helps you compare options.
26,985 articlesViking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
A veteran SpaceX backer contends the $2 trillion IPO valuation understates the long-term growth in space infrastructu...
When a chief financial officer sells a large block of stock, investors sit up and take notice. This article breaks do...
Peek behind the curtain of a renowned star’s private life. This fictional profile of the Neill family reveals how mon...
The AI era has reshaped Palantir's role in enterprise data. This guide weighs the buy, sell, hold case for 2026 with ...
With burnout on the rise in early 2026, workers seek structured ways to reduce load without leaving their jobs. Inves...
Explore how Solo Brands (SBDS) 2025 could unfold, with a clear view of revenue drivers, margins, and strategic bets. ...
A high-profile return to release strategy reshapes expectations for both moviegoers and investors as the devil wears ...
Citi sees the recent aerospace pullback as a rare entry point for Boeing, lifting the target to $260 and signaling a ...
South Korea's possible investment in NuScale Power's SMR program could shift the nuclear landscape and offer new oppo...
SailPoint faced a sharp pullback after its latest results, sparking questions about growth and profitability. This ar...
Singapore's financial regulator placed Hyperliquid on its Investor Alert List, marking a consumer-protection test for...